https://pro.quotidianosanita.it/asma-bpco/depemokimab-il-primo-biologico-semestrale-i-dati-sulla-sicurezza/ 2026-04-21T08:05:00+00:00 https://pro.quotidianosanita.it/asma-bpco/bpco-e-herpes-zoster-un-binomio-critico-tra-fragilit-clinica-e-costi-sanitari/ 2026-04-21T08:44:00+00:00 https://pro.quotidianosanita.it/asma-bpco/screening-bpco-perch-la-diagnosi-precoce-un-investimento-sostenibile/ 2026-04-21T09:17:00+00:00 https://pro.quotidianosanita.it/quotidianooncologia/tumore-del-colon-retto-locse-lancia-lallarme-casi-in-aumento-tra-i-giovani-screening-ancora-troppo-bassi/ 2026-04-21T10:49:00+00:00 https://pro.quotidianosanita.it/quotidianooncologia/melanoma-in-italia-2-600-casi-ereditari-allanno-imi-prevenzione-sia-anche-esami-genetici-e-sorveglianza-cutanea/ 2026-04-21T10:53:00+00:00